146 related articles for article (PubMed ID: 9839269)
1. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
2. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
3. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
[TBL] [Abstract][Full Text] [Related]
4. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
5. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
Manonai J; Theppisai U; Chittacharoen A
J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
[TBL] [Abstract][Full Text] [Related]
6. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.
Casper F; Petri E
Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(3):171-6. PubMed ID: 10430010
[TBL] [Abstract][Full Text] [Related]
7. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
8. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
Manonai J; Theppisai U
J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
[TBL] [Abstract][Full Text] [Related]
10. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
11. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
12. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
13. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
14. The role of estrogen in female urinary incontinence and urogenital aging: a review.
Lovatsis D; Drutz HP
Ostomy Wound Manage; 1998 Jun; 44(6):48-53. PubMed ID: 9739277
[TBL] [Abstract][Full Text] [Related]
15. Effect of estradiol valerate and levonorgestrel on vaginal health.
Manonai J; Chittacharoen A; Theppisai U
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354
[TBL] [Abstract][Full Text] [Related]
16. Urogenital aging: solutions in clinical practice.
Notelovitz M
Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S35-9. PubMed ID: 9386214
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
18. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
19. Current overview of the management of urogenital atrophy in women with breast cancer.
Pruthi S; Simon JA; Early AP
Breast J; 2011; 17(4):403-8. PubMed ID: 21645165
[TBL] [Abstract][Full Text] [Related]
20. Transdermal estradiol. A potentially improved method of hormone replacement.
Judd HL
J Reprod Med; 1994 May; 39(5):343-52. PubMed ID: 8064701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
